Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 54.63
(-0.96%)
INR 54.63
(-0.96%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 467.3 Million INR | -29.8% |
| 2022 | 574.22 Million INR | 5.05% |
| 2021 | 546.63 Million INR | 23.16% |
| 2020 | 443.84 Million INR | 439.08% |
| 2019 | 82.33 Million INR | 404.63% |
| 2018 | 16.31 Million INR | 312.49% |
| 2017 | -7.67 Million INR | 2.75% |
| 2016 | -7.89 Million INR | -1036.32% |
| 2015 | -694.83 Thousand INR | -143.2% |
| 2014 | 1.6 Million INR | 1.18% |
| 2013 | 1.58 Million INR | 160.86% |
| 2012 | 609.42 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 73.74 Million INR | -29.12% |
| 2023 Q4 | 104.04 Million INR | -20.25% |
| 2023 Q3 | 130.46 Million INR | 25.65% |
| 2023 Q1 | 75.46 Million INR | -33.42% |
| 2023 FY | 403.08 Million INR | -29.8% |
| 2023 Q2 | 103.83 Million INR | 37.59% |
| 2022 Q1 | 113.35 Million INR | -25.04% |
| 2022 FY | 574.22 Million INR | 5.05% |
| 2022 Q4 | 113.35 Million INR | 7.55% |
| 2022 Q3 | 105.39 Million INR | 39.66% |
| 2022 Q2 | 75.46 Million INR | -33.42% |
| 2021 Q3 | 130.01 Million INR | -7.45% |
| 2021 Q2 | 140.47 Million INR | 12.44% |
| 2021 Q4 | 151.21 Million INR | 16.31% |
| 2021 FY | 546.63 Million INR | 23.16% |
| 2021 Q1 | 124.93 Million INR | 25.09% |
| 2020 Q3 | 120.9 Million INR | 2.4% |
| 2020 FY | 443.84 Million INR | 439.08% |
| 2020 Q2 | 118.06 Million INR | 12.82% |
| 2020 Q4 | 99.87 Million INR | -17.39% |
| 2020 Q1 | 104.64 Million INR | 158.86% |
| 2019 Q4 | 40.42 Million INR | 16.83% |
| 2019 Q2 | 15.83 Million INR | 10.83% |
| 2019 Q1 | 14.28 Million INR | -3.47% |
| 2019 FY | 82.33 Million INR | 404.63% |
| 2019 Q3 | 34.6 Million INR | 118.57% |
| 2018 Q1 | -1.3 Million INR | 39.85% |
| 2018 FY | 16.31 Million INR | 312.49% |
| 2018 Q4 | 14.79 Million INR | 24.44% |
| 2018 Q3 | 11.89 Million INR | 664.31% |
| 2018 Q2 | 1.55 Million INR | 219.54% |
| 2017 Q2 | -3.45 Million INR | -422.9% |
| 2017 FY | -7.67 Million INR | 2.75% |
| 2017 Q4 | -2.16 Million INR | -52.53% |
| 2017 Q3 | -1.41 Million INR | 58.95% |
| 2017 Q1 | -660.91 Thousand INR | 90.01% |
| 2016 Q1 | -432.61 Thousand INR | -110.15% |
| 2016 FY | -7.89 Million INR | -1036.32% |
| 2016 Q4 | -6.61 Million INR | -2461.5% |
| 2016 Q3 | -258.21 Thousand INR | -24.42% |
| 2016 Q2 | -207.53 Thousand INR | 52.03% |
| 2015 Q3 | -372 Thousand INR | -85.99% |
| 2015 Q2 | -200 Thousand INR | -267.59% |
| 2015 Q1 | -54.41 Thousand INR | -135.68% |
| 2015 FY | -694.83 Thousand INR | -143.2% |
| 2015 Q4 | -205.86 Thousand INR | 44.66% |
| 2014 Q3 | 1.23 Million INR | 0.0% |
| 2014 FY | 1.6 Million INR | 1.18% |
| 2014 Q4 | 152.47 Thousand INR | -87.6% |
| 2013 FY | 1.58 Million INR | 160.86% |
| 2012 FY | 609.42 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|